- Home
- MNPR vs PVBC Comparison
MNPR vs PVBC Comparison
Compare MNPR & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- PVBC
- Stock Information
- Founded
- MNPR 2014
- PVBC 1913
- Country
- MNPR United States
- PVBC United States
- Employees
- MNPR N/A
- PVBC N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- PVBC Major Banks
- Sector
- MNPR Health Care
- PVBC Finance
- Exchange
- MNPR Nasdaq
- PVBC Nasdaq
- Market Cap
- MNPR 248.8M
- PVBC 224.6M
- IPO Year
- MNPR 2019
- PVBC 2015
- Fundamental
- Price
- MNPR $35.71
- PVBC $12.50
- Analyst Decision
- MNPR Strong Buy
- PVBC Hold
- Analyst Count
- MNPR 7
- PVBC 1
- Target Price
- MNPR $62.00
- PVBC $12.50
- AVG Volume (30 Days)
- MNPR 20.7K
- PVBC 68.9K
- Earning Date
- MNPR 08-12-2025
- PVBC 07-24-2025
- Dividend Yield
- MNPR N/A
- PVBC N/A
- EPS Growth
- MNPR N/A
- PVBC 47.48
- EPS
- MNPR N/A
- PVBC 0.62
- Revenue
- MNPR N/A
- PVBC $59,149,000.00
- Revenue This Year
- MNPR N/A
- PVBC $9.73
- Revenue Next Year
- MNPR N/A
- PVBC $4.87
- P/E Ratio
- MNPR N/A
- PVBC $20.19
- Revenue Growth
- MNPR N/A
- PVBC 0.65
- 52 Week Low
- MNPR $2.15
- PVBC $10.03
- 52 Week High
- MNPR $54.30
- PVBC $13.02
- Technical
- Relative Strength Index (RSI)
- MNPR 43.81
- PVBC 53.08
- Support Level
- MNPR $30.51
- PVBC $12.00
- Resistance Level
- MNPR $36.51
- PVBC $12.81
- Average True Range (ATR)
- MNPR 3.33
- PVBC 0.17
- MACD
- MNPR -0.95
- PVBC 0.02
- Stochastic Oscillator
- MNPR 37.55
- PVBC 61.73
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.